These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 34416788)
21. Vascularization of Irregular Retinal Pigment Epithelial Detachments in Chronic Central Serous Chorioretinopathy Evaluated With OCT Angiography. de Carlo TE; Rosenblatt A; Goldstein M; Baumal CR; Loewenstein A; Duker JS Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):128-33. PubMed ID: 26878445 [TBL] [Abstract][Full Text] [Related]
22. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability. Goto S; Gomi F; Ueno C; Nishida K Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480 [TBL] [Abstract][Full Text] [Related]
23. FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy? Hwang H; Kim JY; Kim KT; Chae JB; Kim DY Retina; 2020 Sep; 40(9):1724-1733. PubMed ID: 31584559 [TBL] [Abstract][Full Text] [Related]
24. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy. Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370 [TBL] [Abstract][Full Text] [Related]
25. Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response. Amoroso F; Pedinielli A; Cohen SY; Jung C; Chhablani J; Astroz P; Colantuono D; Semoun O; Capuano V; Souied EH; Miere A Eur J Ophthalmol; 2022 Sep; 32(5):2810-2818. PubMed ID: 34846180 [TBL] [Abstract][Full Text] [Related]
32. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630 [TBL] [Abstract][Full Text] [Related]
33. Bullous central serous chorioretinopathy and retinal pigment epithelium sequelae postblunt trauma. Gunna NT; C Parameswarappa D; Rani PK BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32967945 [TBL] [Abstract][Full Text] [Related]
34. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy. Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761 [TBL] [Abstract][Full Text] [Related]
35. Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy. Hayashida M; Miki A; Honda S; Nakamura M Photodiagnosis Photodyn Ther; 2020 Sep; 31():101955. PubMed ID: 32818640 [TBL] [Abstract][Full Text] [Related]
36. Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization. Hage R; Mrejen S; Krivosic V; Quentel G; Tadayoni R; Gaudric A Am J Ophthalmol; 2015 May; 159(5):890-903.e3. PubMed ID: 25709063 [TBL] [Abstract][Full Text] [Related]
37. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105 [TBL] [Abstract][Full Text] [Related]
38. Subretinal hyperreflective material in central serous chorioretinopathy. Sahoo NK; Govindhari V; Bedi R; Goud A; Singh R; Wu L; Chhablani J Indian J Ophthalmol; 2020 Jan; 68(1):126-129. PubMed ID: 31856489 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of Navigated Laser Photocoagulation for Chronic Central Serous Chorioretinopathy: A Retrospective Observational Study. Zhou F; Yao J; Jiang Q; Yang W Dis Markers; 2022; 2022():7792291. PubMed ID: 35465265 [No Abstract] [Full Text] [Related]